Polymorphism Studies​

Polymorphism Studies​

Home/Polymorphism Studies​
image (2)

Related Services

Polymorphism Studies​

Polymorphism Studies​

Polymorphism: From Material Science to a Pillar of Pharmaceutical Development​

Polymorphism was once a topic reserved for materials scientists—but that changed dramatically in 1998 with the high-profile case of Ritonavir, where a sudden polymorphic transformation caused the drug to fail dissolution tests, leading to a product recall. Since then, polymorphism has become a cornerstone of pharmaceutical development, triggering countless studies across the industry.​

At the forefront of this transformation is our expert, Dr. Ravikiran, a true pioneer in pharmaceutical polymorphism. With over 50,000 PXRD scans analyzed, numerous publications, and a role as a reviewer for leading pharmaceutical journals, he has solved some of the industry’s most complex solid-state challenges. As an innovator of novel solid forms, his deep expertise helps pharmaceutical teams navigate the fine line between compliance, performance, and innovation.

Alcoax: Your Complete Partner in Polymorphism Studies​

We offer end-to-end polymorphism solutions tailored to meet both regulatory and patent requirements:

  • Study Design & Testing to effectively respond to regulatory queries​

  • Form Selection Strategy to align with both regulatory expectations and IP goals​

  • Quantification Method Development & Validation using PXRD​

  • Specification Setting for polymorphic forms​

  • Addressing Polymorph Conversions during formulation and storage​

  • Solid Form Screening & Characterization using a suite of techniques: PXRD, DSC, TGA, SEM, FTIR, DVS, and more​

Whether you’re facing a regulatory challenge or looking to future-proof your formulation, Alcoax delivers science-backed, regulator-ready solutions for all your polymorphism study needs.

+60 122124177